Document is current
Any future updates will be listed below
-
Authors
Xu, Wei https://orcid.org/0009-0008-3338-4545
Mesa-Eguiagaray, Ines
Morris, David M.
Wang, Chengjia https://orcid.org/0000-0003-2345-7364
Gray, Calum D. https://orcid.org/0000-0002-2816-4707
Sjöström, Samuel
Papanastasiou, Giorgos
Badr, Sammy https://orcid.org/0000-0002-3485-6531
Paccou, Julien
Wang, Lijuan https://orcid.org/0000-0002-9797-0753
Li, Xue
Timmers, Paul R. H. J. https://orcid.org/0000-0002-5197-1267
Timofeeva, Maria https://orcid.org/0000-0002-2503-4253
Semple, Scott IK
MacGillivray, Tom https://orcid.org/0000-0001-5120-0086
Theodoratou, Evropi https://orcid.org/0000-0001-5887-9132
Cawthorn, William P. https://orcid.org/0000-0001-7832-5057
-
Funding
Funding for this research was provided by:
RCUK | Medical Research Council (MR/S010505/1, MR/S010505/1)
British Heart Foundation (RE/18/5/34216, RG/16/10/32375)
Cancer Research UK (C31250/A22804)
- License Information
-
More Information
Article History
Received: 27 February 2025
Accepted: 11 August 2025
First Online: 23 September 2025
Competing interests
: G.P. is currently an employee of Pfizer; however, Pfizer had no role in the design or interpretation of this research. All other authors declare no competing interests.
